{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:01:37Z","timestamp":1784257297430,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Japan Association of Health Service"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00774-018-0914-3","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T08:04:18Z","timestamp":1520582658000},"page":"273-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Changes in quality of life in patients with postmenopausal osteoporosis receiving weekly bisphosphonate treatment: a 2-year multicenter study in Japan"],"prefix":"10.1007","volume":"37","author":[{"given":"Hiroshi","family":"Hagino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Soen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"914_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/ije\/dyp276","volume":"39","author":"N Yoshimura","year":"2010","unstructured":"Yoshimura N, Muraki N, Oka H, Kawaguchi H, Nakamura K, Akune T (2010) Cohort profile: research on Osteoarthritis\/Osteoporosis Against Disability study. Int J Epidemiol 39:988\u2013995","journal-title":"Int J Epidemiol"},{"key":"914_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00774-009-0080-8","volume":"27","author":"N Yoshimura","year":"2009","unstructured":"Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis\/osteoporosis against disability study. J Bone Miner Metab 27:620\u2013628","journal-title":"J Bone Miner Metab"},{"key":"914_CR3","volume-title":"Guidelines for prevention and treatment of osteoporosis (in Japanese)","author":"Committee for the Development of Guidelines for Prevention and Treatment of Osteoporosis (Japan Osteoporosis Society, The Japanese Society for Bone and Mineral Research and Japan Osteoporosis Foundation)","year":"2015","unstructured":"Committee for the Development of Guidelines for Prevention and Treatment of Osteoporosis (Japan Osteoporosis Society, The Japanese Society for Bone and Mineral Research and Japan Osteoporosis Foundation) (2015) Guidelines for prevention and treatment of osteoporosis (in Japanese). Life Science Publishing Co., Ltd., Tokyo"},{"key":"914_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-009-0125-z","volume":"28","author":"K Kumamoto","year":"2010","unstructured":"Kumamoto K, Nakamura T, Suzuki T, Gorai I, Fujinawa O, Ohta H, Shiraki M, Yoh K, Fujiwara S, Endo N, Matsumoto T (2010) Validation of the Japanese Osteoporosis Quality of Life Questionnaire. J Bone Miner Metab 28:1\u20137","journal-title":"J Bone Miner Metab"},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00223-011-9545-6","volume":"90","author":"H Hagino","year":"2012","unstructured":"Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14\u201321","journal-title":"Calcif Tissue Int"},{"key":"914_CR6","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00198-015-3124-z","volume":"26","author":"Y Tsukutani","year":"2015","unstructured":"Tsukutani Y, Hagino H, Ito Y, Nagashima H (2015) Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis. Osteoporos Int 26:2249\u20132255","journal-title":"Osteoporos Int"},{"key":"914_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00774-007-0768-6","volume":"25","author":"M Kamatari","year":"2007","unstructured":"Kamatari M, Koto S, Ozawa N, Urao C, Suzuki Y, Akasaka E, Yanagimoto K, Sakota K (2007) Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab 25:302\u2013309","journal-title":"J Bone Miner Metab"},{"key":"914_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16\u201335","journal-title":"J Bone Miner Res"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0543-5","journal-title":"Osteoporos Int"},{"key":"914_CR10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1185\/03007995.2011.580341","volume":"27","author":"H Orimo","year":"2011","unstructured":"Orimo H, Nakamura T, Fukunaga M, Ohta H, Hosoi T, Uemura Y, Kuroda T, Miyakawa N, Ohashi Y, Shiraki M, A-TOP (Adequate Treatment of Osteoporosis) Research Group (2011) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)\u201402. Curr Med Res Opin 27:1273\u20131284","journal-title":"Curr Med Res Opin"},{"key":"914_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00774-012-0372-2","volume":"30","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Osawa M, Itoh M, Yamaguchi H, Iinuma N, Hayakawa Y, Suzuki H, Kamisaki T, Iwayama S, Nishikawa M (2012) The effect of risedronate (17.5\u00a0mg\/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study. J Bone Miner Metab 30:715\u2013721","journal-title":"J Bone Miner Metab"},{"key":"914_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clinthera.2013.12.007","volume":"36","author":"H Ohta","year":"2014","unstructured":"Ohta H, Uemura Y, Nakamura T, Fukunaga M, Ohashi Y, Hosoi T, Mori S, Sugimoto T, Itoi E, Orimo H, Shiraki M, Adequate Treatment of Osteoporosis (A-TOP) Research Group (2014) Serum 25-hydroxyvitamin D level as an independent determinant of quality of life in osteoporosis with a high risk for fracture. Clin Ther 36:225\u2013235","journal-title":"Clin Ther"},{"key":"914_CR13","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00198-011-1868-7","volume":"23","author":"AS Carmel","year":"2012","unstructured":"Carmel AS, Shieh A, Bang H, Bockman RS (2012) The 25(OH)D level needed to maintain a favorable bisphosphonate response is\u00a0\u2265\u00a033\u00a0ng\/ml. Osteoporos Int 23:2479\u20132487","journal-title":"Osteoporos Int"},{"key":"914_CR14","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Institute of Medicine, Food and Nutrition Board","year":"2010","unstructured":"Institute of Medicine, Food and Nutrition Board (2010) Dietary reference intakes for calcium and vitamin D. National Academy Press, Washington, DC"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12199-010-0162-1","volume":"16","author":"A Fujikawa","year":"2011","unstructured":"Fujikawa A, Suzue T, Jitsunari F, Hirao T (2011) Evaluation of health-related quality of life using EQ-5D in Takamatsu, Japan. Environ Health Prev Med 16:25\u201335","journal-title":"Environ Health Prev Med"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-018-0914-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T06:18:26Z","timestamp":1567059506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-018-0914-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s00774-018-0914-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"28 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was funded by the Japan Association of Health Service.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}